The production method includes: a gel-crushing step of grinding a crosslinked hydrogel polymer to obtain a particulate crosslinked hydrogel polymer; a heating drying step of obtaining dried particles from the particulate crosslinked hydrogel polymer by using a continuous stirring drying machine; a post-crosslinking step of post-crosslinking the particulate crosslinked hydrogel polymer or the dried particles; and a sizing step of adjusting a particle size of the dried particles or the post-crosslinked dried particles to obtain water-absorbent resin powder. The particulate crosslinked hydrogel polymer contains a gel fluidizer. A gel temperature of the particulate crosslinked hydrogel polymer containing the gel fluidizer, the gel temperature being measured by a contact thermometer, is not lower than 50 C. In the production method, the dried particles or the post-crosslinked dried particles is forcedly cooled before the sizing step.

The production method includes a drying step of drying a particulate crosslinked hydrogel polymer obtained by polymerizing a monomer, which is a material of a water-absorbent resin, using a heating device to obtain dried particles. The heating device includes: a rotary container that contains the particulate crosslinked hydrogel polymer therein and rotates; and a plurality of heating tubes that are located within the rotary container, extend in an axial direction of the rotary container, and rotate together with the rotary container. A gel temperature of the particulate crosslinked hydrogel polymer to be subjected to the drying step, the gel temperature being measured by a contact thermometer, is not lower than 50 C.

Provided are methods for the treatment and prevention of fibrosis at a medical implant site in a subject, by administering a microporous gel to the medical implant site. Also provided are methods of preventing or treating an infection at the medical implant site in a subject. Also disclosed herein are methods for promoting healing of a wound or surgical incision at a medical implant site in a subject, by administering a microporous gel to the medical implant site. The microporous gel may be fluidic during application and annealed or crosslinked after application. The microporous gels may contain various therapeutic agents, including antibiotics and analgesics, throughout the gel.

Disclosed herein are systems for promoting healing of a wound or surgical incision at a medical device site (e.g., implanted medical device) in a subject, by administering a microporous gel to the medical implant site. Also disclosed are systems for the treatment and prevention of infection at a medical implant site in a subject, by administering a microporous gel to the medical implant site. The microporous gel may be fluidic during application and annealed or crosslinked after application. The microporous gels may contain various therapeutic agents, including antibiotics and analgesics, throughout the gel.

Disclosed herein are methods of manufacturing injectable microgel scaffolds, including methods of producing, purifying and concentrating microgel particles therein. The microgel scaffolds of the present disclosure are useful for a wide range of applications, such as stabilizing an implanted medical device in an implant site in a subject. The microgel scaffolds are fluidic during application and annealed or crosslinked after application to the implant site in the subject. The microgel scaffolds may contain various therapeutic agents, including antibiotics and analgesics, throughout the gel.

Provided is a gel composition including a partial degradation product of the galactose moiety of galactoxyloglucan, a compound that is a mixture of one kind or two or more kinds selected from magnesium salt, calcium salt, aluminum salt, and sodium salt, and an aqueous solvent.

The invention relates to a method for treating a nanofibrillar cellulose hydrogel, wherein the method comprises the steps of: providing a nanofibrillar cellulose hydrogel; and subjecting the nanofibrillar cellulose hydrogel to a heat treatment, wherein the heat treatment is carried out by transferring the nanofibrillar cellulose hydrogel through at least one heat exchanger or through at least one insulated holding tube, during which heat treatment the nanofibrillar cellulose hydrogel is kept at a predetermined temperature within the range of 110-150 C. for a period of time in the range of 15 seconds to 20 minutes, wherein the pre-determined temperature and period of time are chosen such that the number of viable micro-organisms in the nanofibrillar cellulose hydrogel is reduced by a factor of at least 10.sup.3.

A gel composition comprises hydrophilic monomers, a cross-linking agent, an initiator, and astaxanthin-modified cyclodextrin complexes. The astaxanthin-modified cyclodextrin complexes comprise astaxanthin and modified cyclodextrin. The modified cyclodextrin has a chemical structure of

##STR00001##

with a hollow cavity, wherein R represents a chemical group having carbon-carbon double bond. The astaxanthin is embedded in the hollow cavity. The disclosure also provides a method for manufacturing a gel composition, and a method for manufacturing an ophthalmic lens using the gel composition.

The invention relates to a method for reducing the viscosity of a nanofibrillar cellulose hydrogel, wherein the method comprises mixing a nanofibrillar cellulose hydrogel with an aqueous growth medium for cell culture, wherein the aqueous growth medium contains one or more salts and optionally one or more sugars, using shearing forces so that a homogeneous dispersion is formed. The invention further relates to a dispersion comprising a nanofibrillar cellulose hydrogel and an aqueous growth medium for cell culture and to a use of an aqueous growth medium.

The present invention relates to a process for the preparation of Sevelamer carbonate from polyallylamine hydrochloride.